CLARK; Michael Philip

Patent Applications and Registrations

Patent applications and USPTO patent grants for CLARK; Michael Philip.The latest application filed is for "modulators of alpha-1 antitrypsin".

Company Profile

0.18.18

CLARK; Michael Philip - Concord MA
Clark; Michael Philip - Maineville OH
Clark; Michael Philip - Loveland OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modulators Of Alpha-1 Antitrypsin App 20200361939 - BANDARAGE; Upul Keerthi ; et al.	2020-11-19
Bicyclic pyrazolone cytokine inhibitors App 20090069355 - Clark; Michael Philip ; et al.	2009-03-12
Bicyclic pyrazolone cytokine inhibitors Grant 7,482,356 - Clark , et al. January 27, 2	2009-01-27
Tri-substituted ureas as cytokine inhibitors Grant 7,449,474 - Brugel , et al. November 11, 2	2008-11-11
Tri-substituted ureas as cytokine inhibitors Grant 7,402,589 - Brugel , et al. July 22, 2	2008-07-22
Pyrrolo[2,3-d]pyrimidine cytokine inhibitors App 20080139588 - Clark; Michael Philip ; et al.	2008-06-12
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 7,368,455 - Clark , et al. May 6, 2	2008-05-06
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 7,326,714 - Clark , et al. February 5, 2	2008-02-05
Pyrrolo[2,3-d]pyrimidine cytokine inhibitors Grant 7,319,102 - Clark , et al. January 15, 2	2008-01-15
Purine cytokine inhibitors Grant 7,256,196 - Sabat , et al. August 14, 2	2007-08-14
6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia Grant 7,087,615 - Clark , et al. August 8, 2	2006-08-08
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines App 20050282844 - Clark, Michael Philip ; et al.	2005-12-22
Tri-substituted ureas as cytokine inhibitors App 20050245555 - Brugel, Todd Andrew ; et al.	2005-11-03
6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones which control inflammatory cytokines Grant 6,960,593 - Clark , et al. November 1, 2	2005-11-01
Tri-substituted ureas as cytokine inhibitors App 20050239811 - Brugel, Todd Andrew ; et al.	2005-10-27
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,919,346 - Clark , et al. July 19, 2	2005-07-19
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines App 20050148610 - Clark, Michael Philip ; et al.	2005-07-07
Bicyclic pyrazolone cytokine inhibitors App 20050113392 - Clark, Michael Philip ; et al.	2005-05-26
6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 6,849,627 - Clark , et al. February 1, 2	2005-02-01
Fused pyrazolone compounds which inhibit the release of inflammatory cytokines Grant 6,821,971 - Clark , et al. November 23, 2	2004-11-23
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,790,846 - Clark , et al. September 14, 2	2004-09-14
Triazole compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,787,555 - Tullis , et al. September 7, 2	2004-09-07
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity App 20040122025 - Clark, Michael Philip ; et al.	2004-06-24
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia App 20040087639 - Clark, Michael Philip ; et al.	2004-05-06
6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 6,730,668 - Clark , et al. May 4, 2	2004-05-04
Triazole compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,727,364 - Tullis , et al. April 27, 2	2004-04-27
6,7-Dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones whinch control inflammatory cytokines App 20040058944 - Clark, Michael Philip ; et al.	2004-03-25
6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines App 20040038971 - Clark, Michael Philip ; et al.	2004-02-26
1,2-dihydropyrazol-3-ones which controls inflammatory cytokines Grant 6,677,337 - Laufersweiler , et al. January 13, 2	2004-01-13
1,2-dihydropyrazol-3-ones which controls inflammatory cytokines App 20030225082 - Laufersweiler, Matthew John ; et al.	2003-12-04
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines App 20030134867 - Clark, Michael Philip ; et al.	2003-07-17
Compound which inhibit the release of inflammatory cytokines App 20030105084 - Clark, Michael Philip ; et al.	2003-06-05
Triazole compounds useful in treating diseases associated with unwanted cytokine activity App 20030100558 - Tullis, Joshua Spector ; et al.	2003-05-29
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity App 20030096814 - Clark, Michael Philip ; et al.	2003-05-22
Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 6,566,357 - Laufersweiler , et al. May 20, 2	2003-05-20
Triazole compounds useful in treating diseases associated with unwanted cytokine activity App 20030013712 - Tullis, Joshua Spector ; et al.	2003-01-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.